Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - Nasdaq - US2582781009 - Common Stock - Currency: USD

142.86  +3.29 (+2.36%)

After market: 142.86 0 (0%)

Fundamental Rating

7

DORM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. DORM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DORM is valied quite expensively at the moment, while it does show a decent growth rate. These ratings would make DORM suitable for quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year DORM was profitable.
DORM had a positive operating cash flow in the past year.
DORM had positive earnings in each of the past 5 years.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

With an excellent Return On Assets value of 9.14%, DORM belongs to the best of the industry, outperforming 96.25% of the companies in the same industry.
DORM's Return On Equity of 16.14% is amongst the best of the industry. DORM outperforms 93.75% of its industry peers.
With an excellent Return On Invested Capital value of 12.70%, DORM belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
DORM had an Average Return On Invested Capital over the past 3 years of 9.34%. This is in line with the industry average of 8.78%.
The last Return On Invested Capital (12.70%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROIC 12.7%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

DORM has a better Profit Margin (10.83%) than 97.50% of its industry peers.
In the last couple of years the Profit Margin of DORM has grown nicely.
The Operating Margin of DORM (15.75%) is better than 98.75% of its industry peers.
In the last couple of years the Operating Margin of DORM has grown nicely.
With an excellent Gross Margin value of 40.88%, DORM belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DORM is creating some value.
DORM has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DORM has been reduced compared to 5 years ago.
The debt/assets ratio for DORM has been reduced compared to a year ago.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

DORM has an Altman-Z score of 4.89. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of DORM (4.89) is better than 86.25% of its industry peers.
DORM has a debt to FCF ratio of 3.31. This is a good value and a sign of high solvency as DORM would need 3.31 years to pay back of all of its debts.
DORM's Debt to FCF ratio of 3.31 is amongst the best of the industry. DORM outperforms 91.25% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that DORM is not too dependend on debt financing.
DORM has a better Debt to Equity ratio (0.31) than 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Altman-Z 4.89
ROIC/WACC1.32
WACC9.64%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.74 indicates that DORM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.74, DORM belongs to the top of the industry, outperforming 82.50% of the companies in the same industry.
DORM has a Quick Ratio of 1.21. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.21, DORM is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 1.21
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

6

3. Growth

3.1 Past

DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.49%, which is quite impressive.
The Earnings Per Share has been growing by 21.83% on average over the past years. This is a very strong growth
Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 6.76% in the last year.
DORM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%

3.2 Future

DORM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.00% yearly.
DORM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.76% yearly.
EPS Next Y11.5%
EPS Next 2Y10%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.75%
Revenue Next 2Y4.76%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.34, the valuation of DORM can be described as rather expensive.
DORM's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of DORM to the average of the S&P500 Index (26.41), we can say DORM is valued slightly cheaper.
The Price/Forward Earnings ratio is 16.54, which indicates a correct valuation of DORM.
63.75% of the companies in the same industry are cheaper than DORM, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.87, DORM is valued rather cheaply.
Industry RankSector Rank
PE 17.34
Fwd PE 16.54
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

70.00% of the companies in the same industry are cheaper than DORM, based on the Enterprise Value to EBITDA ratio.
62.50% of the companies in the same industry are cheaper than DORM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.28
EV/EBITDA 12.38
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DORM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)1.51
PEG (5Y)0.79
EPS Next 2Y10%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DORMAN PRODUCTS INC

NASDAQ:DORM (8/11/2025, 8:27:31 PM)

After market: 142.86 0 (0%)

142.86

+3.29 (+2.36%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners86.17%
Inst Owner Change1.4%
Ins Owners10.8%
Ins Owner Change2.63%
Market Cap4.36B
Analysts82
Price Target148.67 (4.07%)
Short Float %4.01%
Short Ratio6.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.85%
Min EPS beat(2)11.58%
Max EPS beat(2)36.11%
EPS beat(4)4
Avg EPS beat(4)20.79%
Min EPS beat(4)9.67%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)21.58%
EPS beat(12)7
Avg EPS beat(12)9.41%
EPS beat(16)8
Avg EPS beat(16)6.6%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.34%
Revenue beat(4)2
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.75%
Revenue beat(12)3
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)0.63%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.04%
EPS NY rev (1m)0%
EPS NY rev (3m)1.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.34
Fwd PE 16.54
P/S 2.09
P/FCF 31.28
P/OCF 24.84
P/B 3.11
P/tB 6.34
EV/EBITDA 12.38
EPS(TTM)8.24
EY5.77%
EPS(NY)8.64
Fwd EY6.05%
FCF(TTM)4.57
FCFY3.2%
OCF(TTM)5.75
OCFY4.03%
SpS68.38
BVpS45.88
TBVpS22.54
PEG (NY)1.51
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROCE 16.84%
ROIC 12.7%
ROICexc 13.08%
ROICexgc 20.96%
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
FCFM 6.68%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Debt/EBITDA 1.12
Cap/Depr 64.28%
Cap/Sales 1.73%
Interest Coverage 10.99
Cash Conversion 45.61%
Profit Quality 61.66%
Current Ratio 2.74
Quick Ratio 1.21
Altman-Z 4.89
F-Score7
WACC9.64%
ROIC/WACC1.32
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
EPS Next Y11.5%
EPS Next 2Y10%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%
Revenue Next Year4.75%
Revenue Next 2Y4.76%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.22%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year26.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.44%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y80.56%
OCF growth 3Y32.07%
OCF growth 5Y19.38%